Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.49 |
| ▸ | HRH4 | Q9H3N8 | 6/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.34 |
| ▸ | SLC6A12 | P48065 | 2/20 | 0.34 |
| ▸ | SLC6A11 | P48066 | 2/20 | 0.34 |
| ▸ | SLC6A13 | Q9NSD5 | 2/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.34 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.34 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.34 |
| ▸ | CDC42BPB | Q9Y5S2 | 2/20 | 0.34 |
| ▸ | CDC42BPA | Q5VT25 | 1/20 | 0.34 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15944212 | 0.90 | HRH3 (0.51) | HRH3HRH4ROCK2ROCK1CDC42BPB | |
| Immepip SCHEMBL6347746 | 0.89 | HRH3 (0.46) | HRH3HRH4SLC6A4GBA1 | |
| Immepip SCHEMBL6605805 | 0.88 | HRH3 (0.45) | HRH3HRH4SLC6A4GBA1 | |
| Immepip SCHEMBL6354845 | 0.88 | HRH3 (0.47) | HRH3HRH4SLC6A4GBA1 | |
| SCHEMBL28079718 | 0.81 | — | — | |
| SCHEMBL14307810 | 0.78 | HRH4 (0.42) | HRH3HRH4 | |
| SCHEMBL6449281 | 0.77 | HRH4 (0.44) | HRH3HRH4 | |
| SCHEMBL6353897 | 0.76 | HRH3 (0.49) | HRH3HRH4SLC6A4GBA1 | |
| SCHEMBL1264781 | 0.74 | — | — | |
| SCHEMBL14140514 | 0.74 | HRH3 (0.32) | HRH3HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240269123-A1 | MUSCLE REGENERATION PROMOTER | SATO PHARMACEUTICAL CO., LTD. (JP) | 2024-08-15 | — | — | US | claimed |
| WO-2022255250-A1 | MUSCLE REGENERATION PROMOTER | 佐藤製薬株式会社 | 2022-12-08 | — | — | WO | claimed |
| US-20240269123-A1 | MUSCLE REGENERATION PROMOTER | SATO PHARMACEUTICAL CO., LTD. (JP) | 2024-08-15 | — | — | US | disclosed |
| WO-2022255250-A1 | MUSCLE REGENERATION PROMOTER | 佐藤製薬株式会社 | 2022-12-08 | — | — | WO | disclosed |
| WO-1999031089-A1 | 1-(1H-IMIDAZOL-2-YL)PYRROLIDINE AND 1-(1H-IMIDAZOL-2-YLPIPERIDINE) DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION | SANOFI-SYNTHELABO (FR) | 1999-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240269123-A1 | MUSCLE REGENERATION PROMOTER | MUSK, HRH3, HGF | HRH3 2/4885HRH4 7/4885SLC6A2 1895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.